Objectives-A new 2-dimensional (2D) shear wave elastographic (SWE) device has been developed for the noninvasive assessment of liver fibrosis. Guidelines on measurement acquisition parameters are not yet well established for this technique. Our study aimed to assess 2D SWE measurement variability and to determine the number of measurements required per patient to reliably assess liver stiffness.
T he management of chronic liver disease relies heavily on the accurate estimation of liver fibrosis, as it is an important prognostic indicator of the future clinical outcome. Although liver biopsy remains the reference standard for fibrosis assessment, it has a number of inherent limitations, which have seen its clinical use decline over recent years. The invasive test is painful, results in hospitalization in 3% of patients, and has a procedural mortality rate of approximately 0.01%. 1, 2 The test is also prone to sampling errors, with only 1/50,000th of the total liver volume obtained at biopsy. [3] [4] [5] Increasing numbers of noninvasive elastographic tools have been developed, which allow clinicians to estimate the severity of a patient's liver fibrosis while avoiding the risks of biopsy. These include transient elastography (FibroScan; Echosens, Paris, France), acoustic radiation force impulse (ARFI) imaging (Siemens Medical Solutions, Erlangen, Germany), magnetic resonance elastography, Aixplorer (SuperSonic Imagine, Aix-en-Provence, France), and, more recently, ElastPQ (Philips Healthcare, Bothell, WA). Reliability issues, however, exist for the most widely used of these tools, FibroScan and ARFI, whose performance is variably affected by necroinflammation, 6, 7 obesity, 8, 9 ascites, narrow intercostal spaces, 10 and operator inexperience. 8 Shear wave elastography (SWE) using ARFI technology is now subclassified as point SWE, in which a very small volume of tissue is stimulated, and 2-dimensional (2D) SWE, in which the elasticity profile of a larger section of tissue is evaluated. 11 A new 2D SWE technique has been developed by Toshiba Medical Systems Corporation (Tochigi, Japan), which uses shear waves to interrogate the viscoelastic properties of tissues. Ultrasonic "push pulses" are used to generate shear waves in the liver, whose propagation is subsequently monitored with "tracking pulses," similar to some other technologies in use. Shear wave arrival times (or "wavefronts") at different locations are plotted, allowing a 2D map of shear wave properties within a section of liver to be generated. These shear wave display maps can be viewed in a "continuous" mode; however, a higher-quality "single-shot" mode is chosen for quantitative analysis. This process involves obtaining a static image of shear wave characteristics within an arc-shaped section of the liver measuring approximately 35 mm in maximal width and 30 mm in axial depth. A circular measurement region of interest (ROI) with a fixed 1-cm diameter is subsequently positioned in an area suitable for quantitative assessment (Figure 1 ). The device automatically calculates the shear wave velocity (meters per second) and Young modulus (kilopascals) for the chosen ROI, the former recommended by the manufacturer for liver fibrosis quantification. The standard deviation of shear wave velocities within the measurement ROI (ROI SD) is also generated for each individual measurement ( Figure 2 ). As with other ultrasound-based elastographic tools, 2D SWE is only able to evaluate areas of the liver accessible via a valid acoustic window (ie, predominantly the right hepatic lobe). Although this factor introduces a degree of sampling error, these technologies are nonetheless able to assess a substantially larger area of the liver parenchyma than biopsy.
The technique is novel in the provision of 2 display maps for the single-shot acquisition, which provide different visual representations of the liver's shear wave profile. The first is the "speed smart map" (Figure 1 ), which provides a color representation of shear wave velocities within a section of liver, similar to that used by SuperSonic shear imaging (SuperSonic Imagine). The "propagation map" is, however, unique to the Toshiba system and uses contour lines to depict shear wave arrival times at different points in the tissue (Figure 1 ). These display maps provide different but complementary information regarding regional shear wave propagation. The additional information provided by the propagation map is designed to allow operators to better assess the suitability of single-shot acquisitions for quantitative analysis and to optimize ROI positioning.
The impact of scan acquisition parameters on these technical innovations has not been established, with limited published data currently available for this 2D SWE technique. Although best acquisition practices for related elastographic technologies provide a good starting point, there are several unknowns that prevent their direct implementation for 2D SWE. The aim of our study was therefore to evaluate these technical questions in patients with diffuse liver disease to assist in the formation of acquisition guidelines. This evaluation included analyzing the variability of 2D SWE measurements obtained within each patient, as well the number of 2D SWE measurements required per patient to provide a precise assessment of liver elasticity.
Materials and Methods

Participants
Fifty-five patients with diffuse chronic liver disease of mixed etiology were prospectively enrolled in the study. Participants were recruited consecutively, having been clinically referred for the assessment of liver fibrosis. Patients were required to be older than 18 years for study entry. There were no further exclusion criteria relating to patient demographics, clinical history, or chronic liver disease severity. The study was approved by the Melbourne Health Research Ethics Committee, and all participants provided informed consent before participation.
Patient Clinical Information
Information relating to patient demographics and liver disease etiology was obtained from medical records. ). The presence and severity of steatosis were graded according to the level of echogenicity and beam attenuation observed on B-mode ultrasound imaging. 12 Liver biopsy results were not available.
Shear Wave Elastography
Two-dimensional SWE measurements were acquired with an Aplio 500 Platinum Series ultrasound machine (Toshiba Medical Systems Corporation) using a PVT-375BT transducer (6-1.9 MHz). Measurements were acquired by a single operator, who was 1 of 3 experienced sonographers. All 3 operators received basic training in 2D SWE before study commencement; however, they had substantial point SWE experience, having completed in excess of 100 ARFI scans previously. The absence of ascites was confirmed on B-mode imaging before quantitative assessment. Patients fasted for 6 hours before testing, and measurements were acquired in the supine position with the right arm abducted. The scan was performed via an intercostal approach with breathing held in light suspension. Measurements were taken in a single imaging session of less than 10 minutes' duration, with the transducer firmly applied to achieve acoustic coupling while avoiding compression. Measurements were taken from the right hepatic lobe through a single intercostal space with a good acoustic window. Measurements were obtained in the liver parenchyma away from vascular or biliary structures. Samples were taken from nonidentical positions within these above parameters. The measurement ROI was positioned in areas of greatest shear wave uniformity, based on the combined and equal review of the propagation map and speed smart map. Areas ideal for quantitative assessment were indicated by parallel lines on the propagation map and relatively homogeneous color on the speed smart map ( Figure 1 ). Note was made to avoid areas of nonfilling on the speed smart map and irregular or fragmented lines on the propagation map, which are indicative of invalid shear wave characteristics. On the occasion that a single-shot acquisition showed no areas suitable for quantitative assessment, the single-shot image was reacquired. Although fibrosis may not be uniform, the assumption is made that the most accurate results are likely to be when there is visible homogeneity within the measurement ROI, as it removes artifactual or technical sources of variation. Ten readings were obtained per patient: 1 per single-shot acquisition. Operators were blinded to all individual measurement velocities during the acquisition process via a screen shield. The ratio of the ROI SD to the mean shear wave velocity of the corresponding individual measurement was calculated. This parameter was assessed as a potential indicator of individual measurement reliability, akin to the use of IQR/median ratio in assessing the reliability of measurement sets overall. The skin-to-liver capsule distance was measured to 2 decimal points with the picture archiving and communication system ruler function ( Figure 2 ). The distance from the liver capsule to the ROI center was also manually measured for each individual measurement.
Statistical Analyses
The interquartile range (IQR)/median ratio was assessed for 2D SWE measurement sets. This parameter reflects the amount of spread between acquired measurements and is a primary indicator of measurement variability in both ARFI and FibroScan. [13] [14] [15] The Cronbach a was used to determine the internal consistency of readings, and a Bland-Altman plot was used for the analysis of the optimal measurement number. 16, 17 The measurement distribution was assessed by skewness and kurtosis. 18 The relationships between patient factors and IQR/median ratios were assessed by the Spearman rank correlation for continuous data and the Kruskal-Wallis test for categorical data. The impact of factors affecting the reproducibility of individual measurements (ie, ROI depth and ROI SD/speed ratio) was assessed by calculating the deviation of individual 2D SWE measurements from the set's median velocity of 10 readings. Intraoperator and interoperator reliability were not assessed.
Results
Patient Characteristics
The cohort consisted of 55 patients, of whom 55% were male, with an age range of 21 Table 1 .
Measurement Variability
A large variation in shear wave velocities was observed between individuals (Figure 3) , with the median overall 2D SWE value of patients being 2.10 m/s (quartiles 1-3, 1.81-2.89 m/s). The median IQR of 2D SWE measurement sets was 0.275 (quartiles 1-3, 0.180-0.575), and the median IQR/median ratio was 0.131 (quartiles 1-3, 0.089-0.174). There was very high internal consistency between measurements obtained within each patient, with the Cronbach a being 0.937 for 5 readings.
The number of measurements required to adequately approximate the set's median of 10 measurements was analyzed. When increasing numbers of measurements were obtained/analyzed, the calculated velocity became predictably closer to the set's overall median of 10 readings (Figure 4 ). The median of 5 measurements provided a velocity estimate within 0.11 m/s, or 4.2% of the set's overall median. The Bland-Altman limits of agreement were 20.254 to 0.374 m/s for 5 measurements. The BMI and skin-to-liver capsule distance (SLD) showed the strongest associations with both IQR/median and ROI SD/speed; q indicates quartile.
Two-dimensional SWE velocities from each of the 55 measurement sets did not follow a normal distribution, with kurtosis ranging between 3.2 and 5.6 and skewness ranging between 1.0 and 1.6. Individual 2D SWE sets followed a gamma distribution, with measurements slightly skewed toward higher shear wave velocities.
Factors Affecting Measurement Variability
The association between patient factors and measurement reproducibility was assessed in univariate analyses ( Table 1 ). The BMI was the primary factor associated with increased IQR/median ratios (q 5 0.388; P 5 .01), with overweight and obese patients (BMI > 25 g/m 2 ) having higher average IQR/median ratios than those with a normal BMI (0.149 versus 0.112; P 5 .013). Moderate to severe steatosis on ultrasound imaging, increasing age, and a clinical diagnosis of NAFLD were additional factors that showed nonsignificant trends toward higher IQR/median ratios ( Table 1) .
The skin-to-liver capsule distance also showed a moderately strong correlation with the IQR/median ratio (q 5 0.426; P 5 .002; Table 1 ). Measurements with a skin-to-liver capsule distance of > 2 cm showed considerably greater deviation from the set's median of 10 readings (average deviation, 0.501 versus 0.268 m/s). Skin-to-liver capsule distance values were also closely related to the BMI (q 5 0.787; P 5 .01).
The ROI may be positioned at different depths beneath the liver capsule. A greater spread of measurement velocities was observed when the ROI center was positioned within 1.5 cm of the liver capsule (Table 2) . These subcapsular measurements showed significantly greater deviation from the set's overall speed (average deviation, 0.39 m/s) than measurements taken more deeply in the liver (average deviation, 0.20 m/s; P < .001).
The ROI SD/speed ratio had a strong relationship with the amount that individual measurements deviated from the set's overall median velocity (Table 3) . Measurements with an ROI SD/speed ratio higher than 0.15 showed low reliability, deviating an average of 0.42 m/s from the set's overall median, compared to 0.22 m/s for measurements with an ROI SD/speed ratio of 0.15 or lower (P 5 .001). Patient factors associated with increased ROI SD/speed ratios included an increasing BMI (q 5 0.499; P 5 .003) and skin-to-liver capsule distance (q 5 0.604; P < .001). Weaker correlations were also seen with age (q 5 0.307; P 5 .09) and the clinical diagnosis of NAFLD (P 5 .04). A positive correlation was also observed between ROI SD/speed ratios and median shear wave velocities (q 5 0.496; P < .001). The median ROI SD/speed ratio was also significantly Figure 4 . Closeness in approximation to the set's overall median of 10 measurements, according to the number of measurements obtained/analyzed. The graph shows the average deviation 6 SEM. Five measurements yielded a liver stiffness approximation below the 5% deviation threshold (blue). Four measurements, however, were required if only readings taken greater than 1.5 cm deep to the liver capsule were analyzed (red). Subcapsular measurements showed greater deviation from the set's overall median velocity and higher ROI SD/speed ratios. higher among subcapsular measurements taken within 1 cm from the liver capsule than those taken more deeply in the liver (ROI SD/speed, 0.169 versus 0.117; P 5 .002).
Discussion
The new 2D SWE technique showed high measurement reproducibility, with a low spread in shear wave velocities (ie, low IQR/median ratio) relative to the most widely used elastographic tools in clinical use. 7, 14, 15 Measurement variability, as indicated by the IQR/median ratio, is a powerful predictor of accuracy for both ARFI 13, 14 and transient elastography. 15 The low variability of 2D SWE measurements is therefore encouraging for future accuracy studies.
The low measurement variability of 2D SWE also translated into fewer measurements being required to adequately estimate liver stiffness. Acquiring 5 2D SWE measurements yielded a liver stiffness estimate within 5% of the overall median velocity of 10 readings. This 5% deviation threshold has been previously used to recommend a minimum of 8 measurements for ARFI. 19 Five measurements would therefore appear sufficient for this 2D SWE technique. The level of deviation is unlikely to have a substantial impact on the assignment of fibrosis categories, in view of the broad range of median shear wave velocities observed between patients (Figure 3 ). Given the inherent technical differences between 2D SWE tools, this measurement number recommendation is specific to the Aplio 500 device and may not be directly transferrable to related technologies.
The low intrinsic measurement variability observed with this 2D SWE technique is likely attributable to the provision of the speed smart map and propagation map. The novel propagation map is not shared by other conventional elastographic methods and provides complementary information, which allows operators to better visualize and evaluate regional shear wave propagation characteristics. 20 This additional information may enable operators to better assess single-shot acquisitions, allowing the rejection of acquisitions that are of insufficient quality for quantitative analysis. The display modes also provide guidance for the optimization of ROI positioning, enabling operators to avoid regions with heterogeneous propagation characteristics, which may yield aberrant results.
Our results likely overestimate 2D SWE's measurement variability in optimal conditions. Study operators were inexperienced with 2D SWE at study commencement, which resulted in acquisition of a number of subcapsular measurements. These measurements are associated with reduced measurement reproducibility (described below), and their inclusion in composite analyses may have increased the observed IQR/median ratios. Furthermore, our study had a relatively high prevalence of obesity, which may similarly have elevated the overall measurement variability observed. The recommendation of a minimum of 5 measurements is therefore likely conservative, and fewer readings may be acceptable under optimal conditions. This factor is illustrated in Figure 4 , in which the exclusion of subcapsular measurements alone reduced the measurement requirement to 4. Five readings are, however, an appropriate recommendation for "real-world" conditions and among similar patient populations. The observation that 2D SWE measurement sets do not follow a binomial distribution also suggests that the set's median velocity may be a more robust representation of a patient's overall shear wave velocity than the set's mean.
Obesity
We found the BMI to be the predominant factor affecting measurement variability, with particularly high IQR/ median ratios observed among obese patients. A similar association has been previously reported for ARFI 9, 21 and transient elastography, 8, 9 and our results provide additional evidence of a possible "class effect" of obesity on ultrasound-based elastographic tools in general. Although the impact of obesity on the accuracy of this Individual measurements with an ROI SD/Speed ratio of greater than 0.15 showed increased deviation from the set's overall median velocity.
2D SWE technique requires assessment, our findings provide early caution that similar reliability issues may be encountered among this population subset. Obesity's negative impact on ultrasound elastography has been hypothesized to involve ultrasonic beam attenuation and degradation from increasing depths of subcutaneous adipose tissue. 9, 21 The skin-to-liver capsule distance approximates the amount of subcutaneous adipose tissue traversed by the ultrasonic beam and has been found to be a powerful predictor of measurement reliability in ARFI. 22 We found the skin-to-liver capsule distance to have a stronger correlation with the IQR/ median ratio than the BMI, which lends weight to this hypothesis. This finding is further supported by the observation of higher ROI SD/speed ratios among patients with increased skin-to-liver capsule distances (Table 1) , indicating degradation in shear wave quality from central adiposity.
Although we did not formally control for transducer pressure in this study, we think that it is unlikely to be a major determinant of the skin-to-liver capsule distance. Drawing from unpublished results from our own group looking at 943 patients tested with ARFI by multiple independent operators, we found low interoperator variability in skin-to-liver capsule distance values obtained within each patient. This finding suggests that any potential difference in operator acquisition technique does not have a substantial impact on skin-to-liver capsule distance values. The strength of the correlation between the BMI and skin-to-liver capsule distance further supports the idea that body habitus is the key determinant of the skin-to-liver capsule distance, rather than operator technique.
Region of Interest Depth in the Liver
We found poorer measurement reproducibility when the center of the ROI was positioned within 1.5 cm of the liver capsule. This observation is consistent with existing point SWE studies, which have associated subcapsular readings with artificially elevated fibrosis scores, increased measurement variability, and reduced accuracy. 23, 24 Acoustic radiation force impulse guidelines generally now recommend the measurements be taken at least 1 cm, and preferably 2 cm, from the liver capsule. Our results suggest that a similar recommendation should be instituted for the Toshiba system. The phenomenon has been previously attributed to a band of physiologic fibrosis underlying the liver capsule, resulting in disproportionately high shear wave velocities relative to the remaining liver parenchyma. We also speculate that a more important factor is likely to be subcapsular reverberation, resulting in regional shear wave degradation. This factor is suggested by 2D SWE's speed smart maps, which show an area of heterogeneous shear wave velocity immediately underlying the liver capsule in some patients (Figures 1, 2A ). This regional degradation of shear wave profiles is further evidenced by the observation of higher ROI SD/speed ratios among subcapsular measurements (Table 2) .
Region of Interest SD/Speed Ratio
The ROI SD/speed ratio reflects the variation in shear wave velocities recorded within a measurement ROI on the speed smart map. Measurements with a low ROI SD/speed ratio reflect regions of liver parenchyma with uniform shear wave profiles, whereas noisy or heterogeneous ROIs translate into higher values. We expected that measurements with uniform shear wave profiles would yield the most reliable liver stiffness readings, and our results support this hypothesis. We found a strong positive correlation between measurement variability and the ROI SD/speed ratio, with poor measurement consistency observed once the ROI SD/speed ratio exceeded 0.15.
The ROI SD/speed ratio may represent an objective and quantifiable indicator of individual measurement reliability. It has the advantage of being readily assessable during scan acquisition and therefore has real potential for clinical application. The ROI SD/speed ratio could potentially assist in the optimization of ROI positioning, providing operators with an additional quantifiable indicator of shear wave uniformity in addition to the speed smart map and propagation map. The value could potentially alert operators to issues in the acquisition technique and may present a means of providing dynamic feedback during operator training or technique modification. The ROI SD/speed ratio may also have utility in stratifying the relative reliability of individual measurements, potentially allowing the rejection of unreliable readings from the final measurement set.
Future studies are, however, required to further explore these potential clinical applications. The relationship between the ROI SD/speed ratio and 2D SWE accuracy also requires assessment, as this will help determine the true utility of the ROI SD/speed ratio as a clinical tool. The ROI SD/speed ratio may also have relevance for SuperSonic shear imaging, which also generates a standard deviation of shear wave velocities obtained within each measurement ROI.
Limitations
Our study did have limitations. First, the study was a technical evaluation, which aimed to address very specific questions regarding 2D SWE measurement variability and the required measurement number. Liver biopsy is performed in a minority of patients with chronic liver disease as part of local clinical practice, and a histopathologic correlate was therefore only available for 9 patients in the cohort (biopsy performed a median of 5.4 years from 2D SWE). Due to the very specific question being addressed, performing a liver biopsy for research purposes was thought to be unjustified in this study. As a consequence, the accuracy of this new 2D SWE technology cannot be derived from our results and will need to be assessed, together with intraoperator and interoperator reliability, in future studies. Nonetheless, our results assist in the formation of acquisition protocols, which will facilitate the rigorous and standardized assessment of 2D SWE accuracy and performance in future clinical trials.
The second limitation was the study's small size, the cohort including only 55 patients. The study's primary findings were nonetheless all drawn from results with high statistical significance, which underscores the potential clinical relevance of the study's findings.
Conclusions
The new 2D SWE technique showed low variability between measurements, with a minimum of 5 readings required to provide a reliable estimation of liver fibrosis. Factors associated with increased measurement variability include an increased BMI, a skin-toliver capsule distance of greater than 2 cm, and subcapsular measurements. The ROI SD/speed ratio showed a strong relationship with measurement variability and may allow operators to objectively assess the reliability of individual measurements in real time during the acquisition process.
